Developer docs
API playgroundTry for free, no card

Search company profiles

Abbott Laboratories Pakistan

Full company profile

uuid00081j6

Namestring
Abbott Laboratories Pakistan
Legal namestring
Abbott Laboratories Pakistan Limited
Websiteurl
pk.abbott
Company typeenum
Public
Founded yearint
1948
Descriptiontext

Abbott Laboratories Pakistan Limited is a public limited company incorporated in Pakistan and listed on the Pakistan Stock Exchange under the ticker symbol ABOT, operating as a subsidiary of global healthcare conglomerate Abbott Laboratories. Headquartered in Karachi and established in 1948, the company maintains operations across 1,001-5,000 employees and four core product verticals: Nutrition (dietary and nutritional supplements), Diagnostics (laboratory and point-of-care diagnostic solutions), Diabetes Care (including the FreeStyle Libre continuous glucose monitoring system), and Pharmaceuticals (prescription and over-the-counter medications).

Its product portfolio originates substantially from global Abbott R&D and is commercialized locally through established distribution channels including pharmaceutical wholesalers, diagnostic lab networks, hospital supply chains, and retail pharmacies. Pricing is not publicly disclosed on the Pakistan website; revenue mechanics consist of B2B sales to healthcare enterprises and B2C sales to patients through retail and clinical channels. Technology differentiators in the portfolio include the FDA-cleared FreeStyle Libre CGM system and wearable devices integrating advanced sensors with generative AI capabilities, both of which represent technology transfer from the parent group's innovation pipeline rather than indigenous local R&D.

The customer base is horizontally diversified across healthcare providers (hospitals, clinics, laboratories) and end patients, with investor relations and shareholder services as a secondary segment. FY2025 reported earnings per share of Rs. 81.37 (up from Rs. 53.46 in FY2024), break-up value per share of Rs. 323.04 (vs. Rs. 242.33), and a price-earnings ratio of 12.91x (vs. 23.15x), indicating strong earnings expansion relative to share price. Governance infrastructure includes EY Ford Rhodes as auditors, a dedicated Company Secretary (Muhammad Usama Jamil), and FAMCO as share registrar.

Short descriptiontext

Abbott Laboratories Pakistan Limited, a Karachi-based public subsidiary of Abbott Laboratories, manufactures and distributes pharmaceutical, diagnostic, diabetes care (FreeStyle Libre), and nutrition products across Pakistan through wholesale, hospital, lab, and pharmacy channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
10,001+
akta.pro rankint
HeadquartersKarachi, Pakistan
HQ citystring
Karachi
HQ countrystring
Pakistan
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, diabetes care devices, diagnostic testing solutions, nutritional supplements, medical devices
Industry3 codes
PRIMARYHLAIAJAD
Hospital & Health-System Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYCRADAGAN
Medical Nutrition & Meal Replacement (RTD, Bars, Powders)
SECONDARYHLACAKAI
Medication Inventory, Procurement & Supply Chain (Pharmacy)
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
NAICS code3 codes
  • Pharmaceutical and Medicine Manufacturing32541
  • Pharmaceutical Preparation Manufacturing325412
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code3 codes
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Biological Products, (No Disgnostic Substances)2836
  • Surgical & Medical Instruments & Apparatus3841
Product category
Pharmaceuticals and Healthcare Products
Social media profiles3 records
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Abbott Laboratories Pakistan manufactures and distributes a diversified healthcare product portfolio organized into four categories: Nutrition (dietary and nutritional products), Diagnostics (laboratory and point-of-care testing solutions), Diabetes Care (glucose monitoring products including the FreeStyle Libre CGM system), and Pharmaceuticals (prescription and over-the-counter medications). The company serves healthcare professionals and patients across Pakistan with integrated health solutions spanning prevention, diagnosis, and treatment.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Abbott Laboratories Pakistan operates as a subsidiary of Abbott Laboratories, offering a diversified healthcare product portfolio organized into four main categories: Nutrition (dietary and nutritional products), Diagnostics (laboratory and point-of-care diagnostic solutions), Diabetes Care (glucose monitoring products including FreeStyle Libre), and Pharmaceuticals (prescription and over-the-counter medications). The company positions itself as a healthcare solutions provider focused on creating healthy possibilities through its products.

Product and service1 record
1FreeStyle Libre Continuous Glucose Monitoring System
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Multinational pharma subsidiary operating in Pakistan across prescription medicines, vaccines, and consumer health. Directly competes with Abbott Pakistan in the same therapeutic categories and channels (hospitals, pharmacies, distributors), making it the closest Pakistan-market peer.

TypeDirect peer
Description

Multinational pharma subsidiary offering prescription drugs, vaccines, and consumer healthcare in Pakistan. Comparable to Abbott Pakistan as a foreign-affiliate pharma manufacturer-distributor serving similar hospital, pharmacy, and channel customers.

TypeDirect peer
Description

Subsidiary of global Bayer, present in Pakistan across pharmaceuticals and consumer health. Competes directly with Abbott Pakistan in prescription pharma and consumer health and shares the multinational-affiliate distribution model in the country.

TypeDirect peer
Description

Pakistani conglomerate with a significant pharmaceuticals and consumer products division (formerly Wyeth Pakistan). Comparable to Abbott Pakistan as a domestic manufacturer-distributor of pharma, nutrition, and consumer health products sold through similar trade channels.

TypeDirect peer
Description

Pakistan-based pharma manufacturer with a broad prescription and OTC portfolio. Competes with Abbott Pakistan across multiple therapeutic categories and channels, representing a strong local multinational-style competitor.

6The Searle Company
TypeDirect peer
Description

Pakistani pharma manufacturer listed on PSX with a diversified prescription and consumer health portfolio. Directly competes with Abbott Pakistan in branded pharma and shares PSX listing and distribution through hospitals, pharmacies, and modern trade.

TypeDirect peer
Description

Pakistani pharma company with branded generics and consumer health products. Overlaps with Abbott Pakistan in therapeutic coverage and the Pakistan hospital and pharmacy channels.

TypeDirect peer
Description

PSX-listed Pakistani pharma manufacturer with branded prescription drugs and a partnership/licensing model similar to multinational subsidiaries. Comparable to Abbott Pakistan in operating footprint and channel coverage in Pakistan.

TypeDirect peer
Description

Multinational pharma subsidiary offering prescription and consumer health products in Pakistan. Comparable as a foreign-affiliate pharma operator with similar product mix, regulatory exposure, and distribution model.

TypeDirect peer
Description

Pakistani pharma manufacturer with branded prescription, OTC, and consumer health portfolio. Competes with Abbott Pakistan in multiple therapeutic areas and serves an overlapping Pakistan customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Abbott Laboratories Pakistan

Pharmaceuticals and Healthcare Productspk.abbott

Abbott Laboratories Pakistan Limited, a Karachi-based public subsidiary of Abbott Laboratories, manufactures and distributes pharmaceutical, diagnostic, diabetes care (FreeStyle Libre), and nutrition products across Pakistan through wholesale, hospital, lab, and pharmacy channels.

What Abbott Laboratories Pakistan does

Abbott Laboratories Pakistan Limited is a public limited company incorporated in Pakistan and listed on the Pakistan Stock Exchange under the ticker symbol ABOT, operating as a subsidiary of global healthcare conglomerate Abbott Laboratories. Headquartered in Karachi and established in 1948, the company maintains operations across 1,001-5,000 employees and four core product verticals: Nutrition (dietary and nutritional supplements), Diagnostics (laboratory and point-of-care diagnostic solutions), Diabetes Care (including the FreeStyle Libre continuous glucose monitoring system), and Pharmaceuticals (prescription and over-the-counter medications).

Its product portfolio originates substantially from global Abbott R&D and is commercialized locally through established distribution channels including pharmaceutical wholesalers, diagnostic lab networks, hospital supply chains, and retail pharmacies. Pricing is not publicly disclosed on the Pakistan website; revenue mechanics consist of B2B sales to healthcare enterprises and B2C sales to patients through retail and clinical channels. Technology differentiators in the portfolio include the FDA-cleared FreeStyle Libre CGM system and wearable devices integrating advanced sensors with generative AI capabilities, both of which represent technology transfer from the parent group's innovation pipeline rather than indigenous local R&D.

The customer base is horizontally diversified across healthcare providers (hospitals, clinics, laboratories) and end patients, with investor relations and shareholder services as a secondary segment. FY2025 reported earnings per share of Rs. 81.37 (up from Rs. 53.46 in FY2024), break-up value per share of Rs. 323.04 (vs. Rs. 242.33), and a price-earnings ratio of 12.91x (vs. 23.15x), indicating strong earnings expansion relative to share price. Governance infrastructure includes EY Ford Rhodes as auditors, a dedicated Company Secretary (Muhammad Usama Jamil), and FAMCO as share registrar.

Abbott Laboratories Pakistan firmographics

Firmographics
Name
Abbott Laboratories Pakistan
Legal name
Abbott Laboratories Pakistan Limited
Website
https://pk.abbott
Company type
Public
Founded year
1948
Operating status
Operating
Headcount range
10,001+ employees
Short description
Abbott Laboratories Pakistan Limited, a Karachi-based public subsidiary of Abbott Laboratories, manufactures and distributes pharmaceutical, diagnostic, diabetes care (FreeStyle Libre), and nutrition products across Pakistan through wholesale, hospital, lab, and pharmacy channels.
Ownership category
akta.pro rank

Abbott Laboratories Pakistan industry classification

Industry
Product category
Pharmaceuticals and Healthcare Products
NAICS
Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Biological Products, (No Disgnostic Substances) (2836), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAIAJAD
Hospital & Health-System Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYCRADAGAN
Medical Nutrition & Meal Replacement (RTD, Bars, Powders)
SECONDARYHLACAKAI
Medication Inventory, Procurement & Supply Chain (Pharmacy)
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

Keywords

  • Pharmaceutical manufacturing
  • Diabetes care devices
  • Diagnostic testing solutions
  • Nutritional supplements
  • Medical devices

Where Abbott Laboratories Pakistan is headquartered

Location

Headquarters

HQ city
Karachi
HQ country
Pakistan
HQ region
Asia

Offices1 record

Markets served

Abbott Laboratories Pakistan business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Distribution channels1 record

Marketing channels3 records

Abbott Laboratories Pakistan product offering

Product offering

Core offering

Abbott Laboratories Pakistan manufactures and distributes a diversified healthcare product portfolio organized into four categories: Nutrition (dietary and nutritional products), Diagnostics (laboratory and point-of-care testing solutions), Diabetes Care (glucose monitoring products including the FreeStyle Libre CGM system), and Pharmaceuticals (prescription and over-the-counter medications). The company serves healthcare professionals and patients across Pakistan with integrated health solutions spanning prevention, diagnosis, and treatment.

Product overview

Abbott Laboratories Pakistan operates as a subsidiary of Abbott Laboratories, offering a diversified healthcare product portfolio organized into four main categories: Nutrition (dietary and nutritional products), Diagnostics (laboratory and point-of-care diagnostic solutions), Diabetes Care (glucose monitoring products including FreeStyle Libre), and Pharmaceuticals (prescription and over-the-counter medications). The company positions itself as a healthcare solutions provider focused on creating healthy possibilities through its products.

Differentiator

Problem solved

Functional benefit

Products and services

  • FreeStyle Libre Continuous Glucose Monitoring System

Companies that use Abbott Laboratories Pakistan

Customer profile

Segments2 records

Ideal customer profiles2 records

Abbott Laboratories Pakistan technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Abbott Laboratories Pakistan partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves5 records

Expansion highlights3 records

Abbott Laboratories Pakistan competitors and assessment

Company assessment

Direct peers

  • GlaxoSmithKline Pakistan: Multinational pharma subsidiary operating in Pakistan across prescription medicines, vaccines, and consumer health. Directly competes with Abbott Pakistan in the same therapeutic categories and channels (hospitals, pharmacies, distributors), making it the closest Pakistan-market peer.
  • Sanofi Pakistan: Multinational pharma subsidiary offering prescription drugs, vaccines, and consumer healthcare in Pakistan. Comparable to Abbott Pakistan as a foreign-affiliate pharma manufacturer-distributor serving similar hospital, pharmacy, and channel customers.
  • Bayer Pakistan: Subsidiary of global Bayer, present in Pakistan across pharmaceuticals and consumer health. Competes directly with Abbott Pakistan in prescription pharma and consumer health and shares the multinational-affiliate distribution model in the country.
  • ICI Pakistan: Pakistani conglomerate with a significant pharmaceuticals and consumer products division (formerly Wyeth Pakistan). Comparable to Abbott Pakistan as a domestic manufacturer-distributor of pharma, nutrition, and consumer health products sold through similar trade channels.
  • Getz Pharma: Pakistan-based pharma manufacturer with a broad prescription and OTC portfolio. Competes with Abbott Pakistan across multiple therapeutic categories and channels, representing a strong local multinational-style competitor.
  • The Searle Company: Pakistani pharma manufacturer listed on PSX with a diversified prescription and consumer health portfolio. Directly competes with Abbott Pakistan in branded pharma and shares PSX listing and distribution through hospitals, pharmacies, and modern trade.
  • Hilton Pharma: Pakistani pharma company with branded generics and consumer health products. Overlaps with Abbott Pakistan in therapeutic coverage and the Pakistan hospital and pharmacy channels.
  • Ferozsons Laboratories: PSX-listed Pakistani pharma manufacturer with branded prescription drugs and a partnership/licensing model similar to multinational subsidiaries. Comparable to Abbott Pakistan in operating footprint and channel coverage in Pakistan.
  • Pfizer Pakistan: Multinational pharma subsidiary offering prescription and consumer health products in Pakistan. Comparable as a foreign-affiliate pharma operator with similar product mix, regulatory exposure, and distribution model.
  • Highnoon Laboratories: Pakistani pharma manufacturer with branded prescription, OTC, and consumer health portfolio. Competes with Abbott Pakistan in multiple therapeutic areas and serves an overlapping Pakistan customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Abbott Laboratories Pakistan social profiles

Digital presence

Abbott Laboratories Pakistan financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Abbott Laboratories Pakistan leadership team

Management profile

Number of profiles

Profiles1 record

Abbott Laboratories Pakistan funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Abbott Laboratories Pakistan M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abbott Laboratories Pakistan

What does Abbott Laboratories Pakistan do?

Abbott Laboratories Pakistan manufactures and distributes a diversified healthcare product portfolio organized into four categories: Nutrition (dietary and nutritional products), Diagnostics (laboratory and point-of-care testing solutions), Diabetes Care (glucose monitoring products including the FreeStyle Libre CGM system), and Pharmaceuticals (prescription and over-the-counter medications). The company serves healthcare professionals and patients across Pakistan with integrated health solutions spanning prevention, diagnosis, and treatment.

Is Abbott Laboratories Pakistan a public or private company?

Abbott Laboratories Pakistan is a public company. It is classified as public and is currently operating.

When was Abbott Laboratories Pakistan founded?

Abbott Laboratories Pakistan was founded in 1948. It employs 10,001+ people.

Where is Abbott Laboratories Pakistan based?

Abbott Laboratories Pakistan is headquartered in Karachi, Pakistan, in the Asia region.

Who are Abbott Laboratories Pakistan's main competitors?

Direct peers on record are GlaxoSmithKline Pakistan, Sanofi Pakistan, Bayer Pakistan, ICI Pakistan, Getz Pharma, The Searle Company, Hilton Pharma, Ferozsons Laboratories, Pfizer Pakistan and Highnoon Laboratories.

Does Abbott Laboratories Pakistan have an API?

No public API is recorded for Abbott Laboratories Pakistan.

What industry is Abbott Laboratories Pakistan in?

Abbott Laboratories Pakistan's product category is Pharmaceuticals and Healthcare Products. Its primary akta.pro industry code is HLAIAJAD, Hospital & Health-System Pharmaceutical Distributors, with a secondary code of CRADAGAN, Medical Nutrition & Meal Replacement (RTD, Bars, Powders). Its NAICS code is 32541 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Bloomberg Law NewsAbbott Notches Third Bellwether Win in Suits Over Infant FormulaAbbott Laboratories Inc. won a federal court case in Illinois, where the court dismissed suits claiming its infant formula caused a deadly disease in preterm infants. The company successfully argued there was no feasible alternative design for its formula, and this marks its third bellwether victory in a multidistrict litigation.LinkedInMolecular Diagnostics Market 2024-2030: Precision Medicine Revolution Drives 7.10% CAGR in $26.70 Billion Industry TransformationThe global Molecular Diagnostics market was valued at USD 17.65 billion in 2024 and is projected to reach USD 26.70 billion by 2030, growing at a CAGR of 7.10%, driven by precision medicine adoption and rising infectious and chronic disease prevalence. North America leads the market with approximately 40% of global revenue, while the Asia Pacific region emerges as the fastest-growing market expanding at nearly 10% annually. The competitive landscape is dominated by F. Hoffmann-La Roche (approximately 20% market share), Illumina, and Abbott Laboratories, with key growth drivers including next-generation sequencing cost reductions exceeding 80% over the past decade and COVID-19 accelerating global PCR testing capacity from 7.5 million to over 22 million daily tests.PR NewswireNeurology Devices Global Market Report 2019ReportLinker released the 'Neurology Devices Global Market Report 2019', a market research document providing strategic analysis of the global neurology devices sector. The report covers market size, growth forecasts, competitive landscapes, and regional breakdowns for companies such as Medtronic and Abbott Laboratories.